Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Exclusion Criteria

• •Patients having a solely non- plaque form of psoriasis (e.g. erythrodermic, guttate, pustular).
• •Patients with uncontrolled psoriasis under the current treatment.
• •Patients having received topical keratolytic agents for the scalp within the past 2 weeks and topical steroids for the scalp within the past week (prior to inclusion).
• •Patients receiving systemic antipsoriatic drugs, immunosuppressants or systemic corticosteroids (within 4 weeks prior to inclusion).
• •Women who are pregnant or breastfeeding or planning to become pregnant during the observational period.
• •Patients participating in another study using an investigational agent or procedure during participation in the study observation period.
• •Known hypersensitivity to any ingredient in the investigational products' formulations.
• •Having any condition that in the opinion of the investigator makes the participation not be in the best interest of the subject.
• •Employees and staff of the investigator or study site with direct involvement in the study as well as family members of the employee or the investigator.